Germany-based BioNTech and its Chinese partner Shanghai Fosun Pharmaceutical have agreed to provide an initial 100 million doses of the Mainz-headquartered company’s mRNA...
The European Medicines Agency (EMA) on Dec. 21 provisionally cleared EU-wide use of the Pfizer-BioNTech Covid-19 vaccine, which will be marketed under the brand name...
To support worldwide development of Covid-19 drugs and vaccines, CDMO Thermo Fisher Scientific is investing in new facilities for its cell and gene therapy portfolio in...
The US Food and Drug Administration (FDA) granted an Emergency Use Authorization (EUA) for US biotech Moderna’s mRNA-based Covid-19 vaccine on Dec.18, a day after the...
Swedish CDMO Recipharm is investing in a capacity expansion at its facility located south of Tel Aviv in Israel, in order to support growing demand for cGMP clinical...
German pharmaceuticals, chemicals and life sciences group Merck is broadening its manufacturing footprint in the US, splitting a planned €40 million capital investment...
French family-owned CDMO Fareva has signed on to handle fill and finish manufacturing for German biotech CureVac’s mRNA-based Covid-19 vaccine candidate, CVnCoV, at the...
Confirming speculation earlier in the week, Ineos has announced the appointment of former BP chief financial officer, Brian Gilvary to head a new energy company called...
ECBF has announced a second closing of the European Circular Bioeconomy Fund (ECBF). Reaching €175 million, ECBF has more than doubled its fund-size within two months...
Industrial gases group Linde has signed a Memorandum of Understanding (MoU) with Italian energy infrastructure company Snam to jointly develop clean hydrogen projects in...
